Further, activated PSCs can attract CD8+ T cells by secretion of CXCL12, which targets the C-X-C chemokine receptor 4 (CXCR4), thereby preventing them from reaching tumor cells as shown in a murine model [27]. Here, CD8A is linked to neoplasm.